Skip to main content
星昊医药 logo

星昊医药 — Investor Relations & Filings

Ticker · 920017 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2023-09-07 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920017

About 星昊医药

https://www.sunho.com.cn/

Beijing Sunho Pharmaceutical Co., Ltd. is a technology-driven enterprise specializing in the research, development, manufacturing, and commercialization of advanced pharmaceutical preparations. The company focuses on high-barrier drug delivery systems, including sustained-release, controlled-release, and complex injection technologies. Its core business encompasses the production of a diverse portfolio of chemical drugs and biological products, alongside comprehensive Contract Development and Manufacturing Organization (CDMO) services. Sunho Pharmaceutical operates modern, GMP-compliant production facilities designed to support the entire lifecycle of drug development, from pilot-scale testing to large-scale commercial manufacturing. By leveraging its proprietary formulation platforms, the company provides integrated solutions for complex dosage forms, catering to both domestic and international pharmaceutical markets.

Recent filings

Filing Released Lang Actions
关于召开2023年第四次临时股东大会通知公告（提供网络投票）
Regulatory Filings Classification · 95% confidence The document is a notice announcing the convening of the 2023 fourth extraordinary general meeting of shareholders (临时股东大会) for Beijing Xinghao Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed, registration methods, and other logistical information. There is no financial data, no report attached or published, and no detailed financial or management analysis. The document is clearly an announcement of a shareholders meeting, not a report or transcript. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself rather than solicitation materials or voting results, it is best classified as a Regulatory Filing (RNS) because it does not fit the exact definitions of DVA or PSI. The document is short (2216 characters) and is an announcement of a meeting, not a report or voting result. Hence, Regulatory Filings (RNS) is the most appropriate category.
2023-09-07 Chinese
第六届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 14th meeting of the 6th Board of Directors of Beijing Xinghao Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references to related announcements and company charter amendments. The content focuses on board decisions and governance matters, specifically changes to the supervisory board and calling a shareholders meeting. It does not contain financial statements, audit information, or detailed financial data. The document is not a full report but a board meeting resolution announcement. Therefore, it fits best under 'Board/Management Information' (MANG). The document length is short and focused on board decisions, not a report or announcement of a report publication.
2023-09-07 Chinese
监事、监事会主席辞职公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of supervisory board members and the chairman of the supervisory board. It details the resignation dates, reasons, and the impact on the company's board composition. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content clearly relates to changes in the company's board or senior management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification with high confidence.
2023-09-07 Chinese
第七届监事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the third meeting of the seventh Supervisory Board of Beijing Xinghao Pharmaceutical Co., Ltd. It details meeting attendance, resignation of supervisors, nomination of a new supervisor candidate, and proposed amendments to the company's articles of association. The content focuses on board/management changes and governance matters, specifically about the Supervisory Board composition and related corporate governance adjustments. It is not a full report, financial statement, or earnings release, nor is it a simple announcement of a report publication. The document fits best under Board/Management Information (MANG) as it announces changes in the company's supervisory board members and related governance adjustments.
2023-09-07 Chinese
监事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new supervisor (监事) at Beijing Xinghao Pharmaceutical Co., Ltd. It details the nomination, voting results, background of the appointee, and the impact of the appointment on the company. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content is about changes in company governance personnel, specifically the supervisory board. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on the appointment, confirming it is not a full report but an announcement of management changes.
2023-09-07 Chinese
关于拟修订《公司章程》公告
Governance Information Classification · 95% confidence The document is an announcement regarding the proposed amendments to the company's Articles of Association (公司章程). It details specific changes to the supervisory board structure and the rationale behind these changes. The document is a formal notice from the company's board and does not contain financial statements, audit information, or detailed financial data. It is not a report itself but an announcement of governance changes requiring shareholder approval. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-09-07 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.